IDEXX Laboratories, Inc. (LON:0J8P)

Market Cap	45.85B
Revenue (ttm)	3.10B
Net Income (ttm)	764.34M
Shares Out	n/a
EPS (ttm)	9.37
PE Ratio	59.98
Forward PE	53.58
Dividend	n/a
Ex-Dividend Date	n/a

Volume	923
Average Volume	806
Open	730.00
Previous Close	732.69
Day's Range	725.88 - 755.35
52-Week Range	351.94 - 753.62
Beta	1.69
RSI	70.10
Earnings Date	Nov 3, 2025

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1983
• Employees: 11,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0J8P

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Financial numbers in USD